Cargando…
The Neuroprotective Effect of L-Carnitine against Glyceraldehyde-Induced Metabolic Impairment: Possible Implications in Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive regression and memory loss. Dysfunctions of both glucose metabolism and mitochondrial dynamics have been recognized as the main upstream events of the degenerative processes leading to AD. It has been rec...
Autores principales: | Magi, Simona, Preziuso, Alessandra, Piccirillo, Silvia, Giampieri, Francesca, Cianciosi, Danila, Orciani, Monia, Amoroso, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394427/ https://www.ncbi.nlm.nih.gov/pubmed/34440878 http://dx.doi.org/10.3390/cells10082109 |
Ejemplares similares
-
Exploring the Role of NCX1 and NCX3 in an In Vitro Model of Metabolism Impairment: Potential Neuroprotective Targets for Alzheimer’s Disease
por: Preziuso, Alessandra, et al.
Publicado: (2023) -
The Hidden Notes of Redox Balance in Neurodegenerative Diseases
por: Piccirillo, Silvia, et al.
Publicado: (2022) -
Gateways for Glutamate Neuroprotection in Parkinson’s Disease (PD): Essential Role of EAAT3 and NCX1 Revealed in an In Vitro Model of PD
por: Piccirillo, Silvia, et al.
Publicado: (2020) -
A new K(+)channel-independent mechanism is involved in the antioxidant effect of XE-991 in an in vitro model of glucose metabolism impairment: implications for Alzheimer’s disease
por: Piccirillo, Silvia, et al.
Publicado: (2022) -
Excitatory Amino Acid Transporters (EAATs): Glutamate Transport and Beyond
por: Magi, Simona, et al.
Publicado: (2019)